Literature DB >> 16136358

Evolution of health-related quality of life two to seven years after retropubic radical prostatectomy: evaluation by UCLA prostate cancer index.

Aurélien Descazeaud1, Marc Zerbib, Matthias D Hofer, Joël Chaskalovic, Bernard Debré, Michaël Peyromaure.   

Abstract

To determine changes in health-related quality of life (HRQOL) in patients treated with retropubic radical prostatectomy (RP) between two and seven years after surgery. A questionnaire from the University of California Los Angeles Prostate Index was sent to 142 patients previously treated with retropubic RP as mono-therapy for clinically localized prostate cancer. Patients were divided into five groups according to time from surgery. Demographics, clinical and pathological characteristics of patients were compared between these groups. Correlation coefficients controlled for age at the time of questionnaire between HRQOL scores and time from RP were assessed. A total of 105 patients (74%) returned the questionnaire. The mean time from surgery was 48 months (range 25-84). Demographics, clinical and pathological characteristics of patients were not statistically different between time groups. Several recoding items were found to decrease significantly with the time from RP including physical functioning, role limitations due to physical health problem, vitality, and general health. In contrary, urinary, bowel and sexual scores were not significantly correlated to time from RP. Although sexual, urinary and bowel scores seem to remain stable from 2 to 7 years following RP, general health appears to significantly deteriorate with time after RP, independent of the patient's age at the time of the questionnaire.

Entities:  

Mesh:

Year:  2005        PMID: 16136358     DOI: 10.1007/s00345-005-0004-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  23 in total

1.  Is laparoscopic radical prostatectomy better than traditional retropubic radical prostatectomy? An analysis of peri-operative morbidity in two contemporary series in Italy.

Authors:  Walter Artibani; Gaetano Grosso; Giacomo Novara; Giuseppe Pecoraro; Onofrio Sidoti; Alessandra Sarti; Vincenzo Ficarra
Journal:  Eur Urol       Date:  2003-10       Impact factor: 20.096

2.  Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.

Authors:  M S Litwin; D J Pasta; J Yu; M L Stoddard; S C Flanders
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

3.  Cross-cultural validation of the UCLA prostate cancer index.

Authors:  Pierre I Karakiewicz; Michael W Kattan; Simon Tanguay; Mostafa M Elhilali; Michel Bazinet; Peter T Scardino; Armen G Aprikian
Journal:  Urology       Date:  2003-02       Impact factor: 2.649

4.  Radical prostatectomy by the retropubic, perineal and laparoscopic approach: 12 years of experience in one center.

Authors:  Laurent Salomon; Olivier Levrel; Alexandre de la Taille; Aristotelis G Anastasiadis; Fabien Saint; Safawat Zaki; Dimitrios Vordos; Antony Cicco; L Eric Olsson; Andras Hoznek; Dominique Chopin; Clement-Claude Abbou
Journal:  Eur Urol       Date:  2002-08       Impact factor: 20.096

5.  Feasibility and usefulness of laparoscopic radical prostatectomy: Kobe University experience.

Authors:  Isao Hara; Gaku Kawabata; Hideaki Miyake; Shoji Hara; Masato Fujisawa; Hiroshi Okada; Soichi Arakawa; Sadao Kamidono
Journal:  Int J Urol       Date:  2002-11       Impact factor: 3.369

6.  Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy.

Authors:  G Van Andel; A P Visser; M C C M Hulshof; S Horenblas; K H Kurth
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

7.  [UCLA/RAND Cancer Prostate Index quality of life questionnaire after external beam radiotherapy for localized prostate cancer: repercussions of complications and quality of life in general].

Authors:  Christophe Almeras; Marc Zerbib; François Eschwege; Bernard Debré
Journal:  Prog Urol       Date:  2003-04       Impact factor: 0.915

8.  Predicting quality of life after radical prostatectomy: results from CaPSURE.

Authors:  Jim C Hu; Eric P Elkin; David J Pasta; Deborah P Lubeck; Michael W Kattan; Peter R Carroll; Mark S Litwin
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

9.  Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.

Authors:  Tracy M Downs; Natalia Sadetsky; David J Pasta; Gary D Grossfeld; Christopher J Kane; Shilpa S Mehta; Peter R Carroll; Deborah P Lubeck
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

10.  Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

View more
  1 in total

1.  Development and Initial Validation of the Novel Scale for Assessing Quality of Life of Prostate Cancer Patients Receiving Androgen Deprivation Therapy.

Authors:  Yao-Jun Dun; Hui-Xin Liu; Lu-Ping Yu; Qing Li; Xiao-Wei Zhang; Xu Tang; Cai-Peng Qin; Tao Xu
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.